Huabei Pharmaceutical Faces Fund Shortage
This article was originally published in PharmAsia News
Executive Summary
Since signing up as a strategic investor of Huabei Pharmaceutical more than two years ago, Holland DSM has yet to receive the National Development and Reform Commission's nod for the partnership. Without fund injection, Huabei Pharmaceutical faces difficulty in developing new products and its upcoming relocation urgently needs funds. The cash-strapped company hopes to get another investor and is negotiating with China National Offshore Oil Co. to set up a joint venture to develop biobutanol, a biofuel source. However, Huabei Pharmaceutical denied that it is seeking a strategic investor in CNOOC, but rather, a collaboration focusing on certain products. The oil company said only preliminary discussion has taken place to date. (Click here for more - Chinese Language)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.